Patentability of biologics in Canada: beyond patentable subject matter

ISSN： 2046-8954

Source： Pharmaceutical Patent Analyst, Vol.2, Iss.4, 2013-07, pp. : 431-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Male hormonal contraceptives: a potentially patentable and profitable product

By Cornia Paul B Anawalt Bradley D

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 12, 2005-12 ,pp. : 1727-1737

Informa Healthcare

Access to resources Recommend Favorite

Preclinical development of therapeutic biologics

By Baumann Andreas

Expert Opinion on Drug Discovery, Vol. 3, Iss. 3, 2008-03 ,pp. : 289-297

Informa Healthcare

Access to resources Recommend Favorite

Toxicity as a result of immunostimulation by biologics

By Gribble Elizabeth J Sivakumar Pallavar V Ponce Rafael A Hughes Steven D

Expert Opinion on Drug Metabolism and Toxicology, Vol. 3, Iss. 2, 2007-04 ,pp. : 209-234

Informa Healthcare

Access to resources Recommend Favorite

Update on the Use of Biologics in Lupus

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 6, 2014-06 ,pp. : 516-520

Bentham Science Publishers

Access to resources Recommend Favorite

Update on the Use of Biologics in Vasculitides

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 6, 2014-06 ,pp. : 558-562

Bentham Science Publishers

Access to resources Recommend Favorite